Jason Hope Sets Sights On Anti-Aging Revolution

As a futurist and one of the foremost voices in regards to the Internet of Thigns, there is an expectation surrounding Scottsdale-based businessman, Jason Hope. Hope has so often been on the forefront of the technological revolution that he is almost expected to help lead the charge. Hope has taken that expectation to heart and he has used it to fuel his enthusiasm for several incredibly promising sectors for today and into the future. Hope made headlines around the nation when he donated a smooth $500,000 to the SENS Research Foundation in order to support their efforts developing anti-aging therapy and treatment. Why is Hope fascinated by anti-aging research and what are his thoughts on the SENS Foundation? Let’s dig in!

Jason Hope came to prominence as a young entrepreneur when he began investing in the field of mobile communications. Jason Hope saw early on just how important the world of mobile tech was going to be and he placed himself in the right position in order to help engineer momentum within the industry by way of his tech startup, JAWA. Now, Hope is using the momentum from his early successes in order to push toward investing in fields that personally fulfill him and that means investing in the SENS Research Foundation via a generous donation.

The SENS Research Foundation has been in business since 2009. Over the years, the non-profit organization has focused extensively on developing and perfecting therapeutic treatments for some of the most common age-related illnesses known to man. From Alzheimer’s and Parkinson’s to diabetes, the SENS Research Foundation is focused on addressing the very issues that plague our aging bodies. With all of that being said, Jason Hope came across the California-based organization while doing heavy research into the industry and after meeting the Chief Scientific Officer of the SENS Foundation, Dr. Aubrey De Grey, Hope was sold.

Hope’s massive donation immediately went toward kickstarting the SENS Research Facility’s focus on Arteriosclerosis, Arteriosclerosis is a serious problem in our elderly population as it results in the hardening of our arteries which takes a further toll on the rest of our system.

Renovia Inc. Generates $42.3 Million during Its Series B Financing

Marc Beer established Renovia Inc. with the aim of inventing efficient, and cost-friendly diagnostic tools used to manage a range of pelvic floor disorders.

Presently, the start-up has a product pipeline of diagnostic tools that train weakened pelvic floor muscles. Into the bargain, the start-up has advanced data management tools and apps that generate informed diagnostic assessments.

 

On August 2018, the start-up’s chairman and chief executive officer announced that they had acquired $42.3 million from their series B financing. $32.3 of the funds was in the form of equities, while the rest was in the form of venture debt.

The series B financing was supported by Cormorant Asset Management, a hedge fund that supports pooled investment schemes, and Inova Strategic Investments, a principal investor in the US’ healthcare industry. Moreover, the series B financing was supported by other principal investment firms like Western Technology Investment, Longwood Fund, and OSF Ventures. It was supervised by Perceptive Advisers, a consultancy firm that supports various innovations in the United States’ life sciences sector.

 

CEO Marc Beer Renovia divulged that he would use the funds to develop various diagnostic tools, as well as support the start-up’s clinical trials. Moreover, the healthcare start-up could use the funds to coordinate its upcoming commercial launches. Learn more: https://www.slideshare.net/MarcBeer

“We are contented with financial back-up from leading healthcare investors. Our company looks forward to implementing medical solutions that would improve the lives of women living with various pelvic floor disorders,” said Marc Beer.

Renovia Incorporation has been serving millions of women living with urinary incontinence. Already, the start-up has developed an FDA-cleared device that restores the levator plate’s optimal function.

 

A Brief Overview of Marc Beer Renovia

Marc Beer Renovia partnered with Ramon Iglesias, and Yolanda Lorie to co-found Renovia Incorporation. The start-up cooperated with leading medical researchers to develop therapeutic and diagnostic tools that could be used to manage an array of pelvic floor disorders. Mr. Marc Beer has served United States’ life sciences sector for over 25 years. Before launching his start-up, he worked at ViaCell, Minerva Neurosciences Incorporation, and Genzyme. He is an active board member of Miami University Business Advisory Council.